FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2267351428> ?p ?o ?g. }

• W2267351428 endingPage "168" @default.
• W2267351428 startingPage "161" @default.
• W2267351428 abstract "Osteoporosis is characterized by low bone mass and compromised trabecular architecture, and is commonly occurred in post-menopausal women with estrogen deficiency. In addition, prolonged mechanical unloading, i.e., long term bed rest, can exaggerate the bone loss. Sclerostin is a Wnt signaling antagonist and acts as a negative regulator for bone formation. A sclerostin-neutralizing antibody (Scl-Ab) increased bone mineral density in women with postmenopausal osteoporosis and healthy men. The objective of this study was to characterize the condition of bone loss in ovariectomized (OVX) rats with concurrent mechanical unloading and evaluate the effect of sclerostin antibody treatment in mitigating the prospective severe bone loss conditions in this model. Four-month-old OVX- or sham-operated female SD rats were used in this study. They were subjected to functional disuse induced by hind-limb suspension (HLS) or free ambulance after 2days of arrival. Subcutaneous injections with either vehicle or Scl-Ab at 25mg/kg were made twice per week for 5weeks from the time of HLS. μCT analyses demonstrated a significant decrease in distal metaphyseal trabecular architecture integrity with HLS, OVX and HLS+OVX (bone volume fraction decreased by 29%, 71% and 87% respectively). The significant improvements of various trabecular bone parameters (bone volume fraction increased by 111%, 229% and 297% respectively as compared with placebo group) with the administration of Scl-Ab are associated with stronger mechanical property and increased bone formation by histomorphometry. These results together indicate that Scl-Ab prevented the loss of trabecular bone mass and cortical bone strength in OVX rat model with concurrent mechanical unloading. The data suggested that monoclonal sclerostin-neutralizing antibody represents a promising therapeutic approach for severe osteoporosis induced by estrogen deficiency with concurrent mechanical unloading." @default.
• W2267351428 created "2016-06-24" @default.
• W2267351428 creator A5003427958 @default.
• W2267351428 creator A5007947900 @default.
• W2267351428 creator A5011583661 @default.
• W2267351428 creator A5022237310 @default.
• W2267351428 creator A5022289275 @default.
• W2267351428 creator A5032396875 @default.
• W2267351428 creator A5052568719 @default.
• W2267351428 creator A5073780815 @default.
• W2267351428 date "2016-06-01" @default.
• W2267351428 modified "2023-10-16" @default.
• W2267351428 title "Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse" @default.
• W2267351428 cites W1716192158 @default.
• W2267351428 cites W1922851405 @default.
• W2267351428 cites W1970864109 @default.
• W2267351428 cites W1975081085 @default.
• W2267351428 cites W1975421186 @default.
• W2267351428 cites W1978825215 @default.
• W2267351428 cites W1981591594 @default.
• W2267351428 cites W1983220846 @default.
• W2267351428 cites W1986214667 @default.
• W2267351428 cites W1991309445 @default.
• W2267351428 cites W1996446495 @default.
• W2267351428 cites W1998111806 @default.
• W2267351428 cites W1998923855 @default.
• W2267351428 cites W2008187259 @default.
• W2267351428 cites W2011258328 @default.
• W2267351428 cites W2013724724 @default.
• W2267351428 cites W2014049907 @default.
• W2267351428 cites W2016146691 @default.
• W2267351428 cites W2018942999 @default.
• W2267351428 cites W2021829493 @default.
• W2267351428 cites W2031359859 @default.
• W2267351428 cites W2032956576 @default.
• W2267351428 cites W2034085344 @default.
• W2267351428 cites W2042546514 @default.
• W2267351428 cites W2043991983 @default.
• W2267351428 cites W2046992947 @default.
• W2267351428 cites W2051484890 @default.
• W2267351428 cites W2051609594 @default.
• W2267351428 cites W2051748491 @default.
• W2267351428 cites W2054603232 @default.
• W2267351428 cites W2065519748 @default.
• W2267351428 cites W2068916684 @default.
• W2267351428 cites W2074494444 @default.
• W2267351428 cites W2074898328 @default.
• W2267351428 cites W2077422848 @default.
• W2267351428 cites W2080784991 @default.
• W2267351428 cites W2087560312 @default.
• W2267351428 cites W2088466503 @default.
• W2267351428 cites W2091514824 @default.
• W2267351428 cites W2096409094 @default.
• W2267351428 cites W2105638572 @default.
• W2267351428 cites W2108403721 @default.
• W2267351428 cites W2128226103 @default.
• W2267351428 cites W2135671879 @default.
• W2267351428 cites W2143563671 @default.
• W2267351428 cites W2145122914 @default.
• W2267351428 cites W2152136687 @default.
• W2267351428 cites W2156216805 @default.
• W2267351428 cites W2163341100 @default.
• W2267351428 cites W2164137478 @default.
• W2267351428 cites W2256257390 @default.
• W2267351428 cites W2356094064 @default.
• W2267351428 cites W2397074632 @default.
• W2267351428 cites W38486948 @default.
• W2267351428 cites W6237436 @default.
• W2267351428 doi "https://doi.org/10.1016/j.bone.2016.02.005" @default.
• W2267351428 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4862887" @default.
• W2267351428 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26868528" @default.
• W2267351428 hasPublicationYear "2016" @default.
• W2267351428 type Work @default.
• W2267351428 sameAs 2267351428 @default.
• W2267351428 citedByCount "31" @default.
• W2267351428 countsByYear W22673514282016 @default.
• W2267351428 countsByYear W22673514282017 @default.
• W2267351428 countsByYear W22673514282018 @default.
• W2267351428 countsByYear W22673514282019 @default.
• W2267351428 countsByYear W22673514282020 @default.
• W2267351428 countsByYear W22673514282021 @default.
• W2267351428 countsByYear W22673514282022 @default.
• W2267351428 countsByYear W22673514282023 @default.
• W2267351428 crossrefType "journal-article" @default.
• W2267351428 hasAuthorship W2267351428A5003427958 @default.
• W2267351428 hasAuthorship W2267351428A5007947900 @default.
• W2267351428 hasAuthorship W2267351428A5011583661 @default.
• W2267351428 hasAuthorship W2267351428A5022237310 @default.
• W2267351428 hasAuthorship W2267351428A5022289275 @default.
• W2267351428 hasAuthorship W2267351428A5032396875 @default.
• W2267351428 hasAuthorship W2267351428A5052568719 @default.
• W2267351428 hasAuthorship W2267351428A5073780815 @default.
• W2267351428 hasBestOaLocation W22673514281 @default.
• W2267351428 hasConcept C104317684 @default.
• W2267351428 hasConcept C126322002 @default.
• W2267351428 hasConcept C134018914 @default.
• W2267351428 hasConcept C137620995 @default.
• W2267351428 hasConcept C170033053 @default.

• next